Streptozocin

链佐星

Report date: 2025/05/15 20:00:08
NME

Base Information

Drug NameStreptozocin
Drug Alias Namestreptozocine链脲霉素Streptozocinum链脲佐菌素链氮霉素 +[14] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlkylating agentsDNA inhibitors
TargetsDNA
Therapy Area/IndicationsZollinger-Ellison SyndromeNeoplasm MetastasisPancreatic Neoplasms +[4] 
Global Approved IndicationsPancreatic Neoplasms
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1982/05/07
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesTeva Pharmaceutical Industries Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTeva Pharmaceuticals Usa IncNational Institute Of Diabetes And Digestive And Kidney Diseases
Active IndicationsN/A
Inactive IndicationsZollinger-Ellison SyndromeNeoplasm MetastasisPancreatic Neoplasms +[4] 

Other Information

ATC CodeL01AD04
Related LinksWikipediaDrugBankKEGG